标题:Vascular endothelium–targeted Sirt7 gene therapy rejuvenates blood vessels and extends life span in a Hutchinson-Gilford progeria model
作者:Sun S.; Qin W.; Tang X.; Meng Y.; Hu W.; Zhang S.; Qian M.; Liu Z.;等 更多
作者机构:[Sun, S] Anti-aging and Regenerative Medicine Research Institution, School of Life Sciences, Shandong University of Technology, Zibo, 255049, China, N 更多
通讯作者:Liu, B(ppliew@szu.edu.cn)
通讯作者地址:[Liu, B] National Engineering Research Center for Biotechnology (Shenzhen), Carson International Cancer Center, Medical Research Center, Shenzhen Univ 更多
来源:Science Advances
出版年:2020
卷:6
期:8
DOI:10.1126/sciadv.aay5556
摘要:Vascular dysfunction is a typical characteristic of aging, but its contributing roles to systemic aging and the therapeutic potential are lacking experimental evidence. Here, we generated a knock-in mouse model with the causative Hutchinson-Gilford progeria syndrome (HGPS) LmnaG609G mutation, called progerin. The Lmnaf/f;TC mice with progerin expression induced by Tie2-Cre exhibit defective microvasculature and neovascularization, accelerated aging, and shortened life span. Single-cell transcriptomic analysis of murine lung endothelial cells revealed a substantial up-regulation of inflammatory response. Molecularly, progerin interacts and destabilizes deacylase Sirt7; ectopic expression of Sirt7 alleviates the inflammatory response caused by progerin in endothelial cells. Vascular endothelium–targeted Sirt7 gene therapy, driven by an ICAM2 promoter, improves neovascularization, ameliorates aging features, and extends life span in Lmnaf/f;TC mice. These data support endothelial dysfunction as a primary trigger of systemic aging and highlight gene therapy as a potential strategy for the clinical treatment of HGPS and age-related vascular dysfunction. Copyright © 2020 The Authors
收录类别:SCOPUS
资源类型:期刊论文
原文链接:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079606332&doi=10.1126%2fsciadv.aay5556&partnerID=40&md5=09766fa1b7b67294c8673e68b4661d71
TOP